Jinjia 2024 Mid-Year Report: Revenue Plummets 27% to 1.484 Billion Yuan, New Tobacco Business Declines 70%

Business by 2FIRSTS.ai
Aug.26.2024
Jinjia 2024 Mid-Year Report: Revenue Plummets 27% to 1.484 Billion Yuan, New Tobacco Business Declines 70%
Jinjia Group (002191.SZ) released its 2024 interim report, showing a decrease in revenue and profit compared to last year.

Recently, Jingjia Corporation (002191.SZ) released its 2024 semi-annual report.

 

  • In terms of revenue and profit, the company achieved a total operating income of 1.484 billion yuan in the reporting period, a year-on-year decrease of 27%, with a net profit of 181 million yuan, a year-on-year decrease of 35.26%; 
  • At the core business level, during the reporting period, the company's new tobacco business operating income decreased by 70.25% to approximately 91 million yuan, and cigarette product operating income decreased by 24.33% compared to the same period last year; 
  • From the same period last year to the present, the proportion of the company's new tobacco business operating income has decreased from 15.13% to 6.16%.

 

Jinjia 2024 Mid-Year Report: Revenue Plummets 27% to 1.484 Billion Yuan, New Tobacco Business Declines 70%
Image source: Jinjia Holdings

 

Jinjia 2024 Mid-Year Report: Revenue Plummets 27% to 1.484 Billion Yuan, New Tobacco Business Declines 70%
Image source: Jinchia Corporation

 

Jingjia Corporation stated that the decrease in revenue from its new tobacco business was primarily due to changes in domestic regulatory policies, which led to a shift in the company's cooperation model with core customers from centralized purchasing to processing services, directly resulting in a reduction in income. Additionally, changes in the international policy environment have further decreased the volume of business orders.

 

Furthermore, the company added that in response to performance pressures, they are currently focusing on stabilizing and expanding their customer base through customized services. They are actively expanding their overseas business layout, exploring and creating new growth opportunities. They are increasing research and development investments, closely aligning with customer and market demands, and continuously optimizing products and services.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Ispire Q2 FY2026 revenue falls to $20.3M as it trims lower-quality customers; A/R down nearly 20%
Ispire Q2 FY2026 revenue falls to $20.3M as it trims lower-quality customers; A/R down nearly 20%
Ispire reported a sharp year-on-year revenue decline in Q2 FY2026 as it shifted away from lower-quality customers, while cutting operating expenses and narrowing its net loss. The company also highlighted improved collections, with net accounts receivable down nearly one-fifth since June 30, 2025, alongside ongoing manufacturing and technology initiatives.
Feb.09 by 2FIRSTS.ai
Reynolds American’s Grizzly expands NASCAR presence, to be primary sponsor for 27 Kaulig Racing Cup races in 2026
Reynolds American’s Grizzly expands NASCAR presence, to be primary sponsor for 27 Kaulig Racing Cup races in 2026
Grizzly Nicotine Pouches, a brand of American Snuff Company (ASC), a Reynolds American unit, said it will increase its NASCAR investment in the 2026 season, serving as primary sponsor for a combined 27 races across Kaulig Racing’s two full-time NASCAR Cup Series cars. The company added that Grizzly is already one of NASCAR’s official partner brands across all NASCAR tracks.
Jan.29 by 2FIRSTS.ai
Nepal: 80 cartons of e-cigarettes seized, valued at US$150,000
Nepal: 80 cartons of e-cigarettes seized, valued at US$150,000
In Nepal’s Mustang district, authorities seized 80 cartons of e-cigarettes valued at NPR 22,459,320 (approximately US$150,000) in Lomanthang Rural Municipality-4, Nechung, and detained a 32-year-old man, Pema Lama. The account says the e-cigarettes were allegedly brought illegally from China three to four days earlier and loaded near the Korala Nepal–China border point before being intercepted.
Jan.13 by 2FIRSTS.ai
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
JT Delivers Record FY2025 Results as RRP Accelerates and Ploom Expands Globally
JT Delivers Record FY2025 Results as RRP Accelerates and Ploom Expands Globally
JT reported record FY2025 revenue and adjusted operating profit, supported by combustible resilience and accelerating reduced-risk product growth. Heated tobacco volumes surged, led by Ploom. The group confirmed a major three-year RRP investment plan and projected further growth in 2026.
Feb.12
Product | Vaporesso lists Vibe SE 2 on official site, offering leather/plated versions and a 1,400mAh battery
Product | Vaporesso lists Vibe SE 2 on official site, offering leather/plated versions and a 1,400mAh battery
Vaporesso has recently listed the Vibe SE 2, a new device in its Vibe series, on the brand’s official website. The product is positioned as an entry-level MTL device and features a 1,400mAh built-in battery with Type-C 1A charging. It is available in two finishes—Leather and Plated—while listings on online retail channels show prices of around $17.99 and £22.99.
Jan.30 by 2FIRSTS.ai